Navigation Links
Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
Date:3/25/2008

PALO ALTO, Calif., March 25 /PRNewswire/ -- Anacor Pharmaceuticals today announced results from a Phase 2a clinical trial of AN2728, an investigational topical anti-inflammatory drug, in patients with psoriasis. The study met its primary endpoint and all secondary endpoints.

In 69 percent of patients, the area treated with AN2728 scored better at the end of therapy than the area treated with the vehicle ointment, compared with six percent of patients in whom the vehicle-treated areas were superior. These results were statistically significant (p<0.001). No drug-related safety issues were reported.

"The results of this study suggest that AN2728 can effectively treat psoriasis in a clinical setting. In addition, plaques treated with AN2728 continued to improve over the course of the 28 days of therapy, suggesting longer-term treatment may have an even greater effect," said Karl R. Beutner, M.D., Ph.D., Senior Vice President and Chief Medical Officer of Anacor. "These results are encouraging for both AN2728 and our entire anti-inflammatory program."

AN2728 is a novel boron-containing small molecule that inhibits the release of pro-inflammatory cytokines including TNF-alpha, IL-12, and IL-23, known mediators of the inflammation associated with psoriasis.

The randomized, double-blind, placebo-controlled trial was designed to evaluate the safety and efficacy of an ointment containing a 5% concentration of AN2728 with patient self-application. Patients with psoriasis commonly have similar areas of psoriasis on their left and right, or front and back sides. The study took advantage of this bilateral characteristic of psoriasis. In this trial, 35 patients treated one of their areas of psoriasis with AN2728 ointment, and a matching area on the opposite side with vehicle alone, twice a day for four weeks.

In addition to this Phase 2a study, two Phase 1b dose-ranging trials have investigated the effects of concentration and formulation
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
2. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
3. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial
4. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
5. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
6. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
7. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
8. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
9. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
10. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
11. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... -- At the upcoming Radiological Society of North ...al Philips Electronics ( PHG, AEX: PHI) will demon...matics solutions designed to directly address the ...vering meaningful imaging innovations that reflect... upgradability. This focus will enable Philips to...
(Date:11/25/2009)...RNewswire/ -- Praxis Electronic Medical Records re...y of Family Physicians, (AAFP) Family Practice Man...r improving medical quality, health maintenance, a...timulus legislation. Praxis also ranked #1 among d...in determining their salary. Finally, Praxis also ...
(Date:11/25/2009)...wswire-FirstCall/ -- Heska Corporation ( HSKA); ("...ic and specialty products to the veterinary indust...ics Corporation for the supply of blood gas produc...arket. ,, (Logo: http://www.newscom.com/cg...oche share the same passion for innovating in the ...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 1Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 2Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 4IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2
...one) decreased the risk of,stroke by 34% in patien...dy adequately treated by antithrombot...ts of a,post-hoc analysis of the data from the ATH...al update session of the European Society of Cardi...results from the landmark,ATHENA study have shown ...
...nch Progress and Adlea Reg...l Today at 11:30 am ET, SOUTH SAN FRANCISCO, Cali...ed today that the company will restructure,operati...development to,accelerate its transition to a spec...company also provided updates on Zingo launch prog...
Other Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5
(Date:11/27/2009)... Three new interactive anatomy education app...ins expand health sciences learning opportunities ... Durham, NC (Vocus) November 27, 2009 -- Modali...WW), a division of Wolters Kluwer Health, today an...ation apps on the App Store. Clemente’s Anat...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... Benton Communications announces a highly ef...for retailers struggling to make an economic recov...6, 2009 -- Flu fears is the type of challenge that...room, according to Dr. David Benton, business grow...s growth system – The Rfactor Intensive . ...
(Date:11/25/2009)...ALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,al...oilsandsoftwareandCalgaryScientificInc.,aleadingpr...dawebversionofAegis(TM)Breast4DAdvancedVisualizati...ttrulyzero-footprintWebclientbasedmedicalimagingof...atformallowsforzero-footprintaccess-requiringnosof...
(Date:11/25/2009)...ANCISCO, Nov. 25 The Bay Area Air ...s first Winter Spare the Air Aler...rning wood, manufactured firelogs or any other sol...till weather will contribute to unhealthy air qual...cer of the Air District. "We,re asking Bay Area re...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...g babies unattended in standard car safety seats c...ms//, according to a recent study. A study co...esearchers at the University of Auckland in New Ze...g of babies in car seats could narrow their upper ...
...le drug for multiple complaints like cholesterol, ...ng designed at Dr Reddy’s the Hyderabad-based labo...e up with a combination of four drugs — a choleste...troke by 60 per cent. It will be available in the ...
... find a combination of healthy and tasty when we d... us any option of low calorie foods//. Mostly...ies we consume each meal, as we depend on the chef...e are becoming more health conscious. At the same ...
...breast cancer patients who are still young, and ha...ait for the stipulated //two years, post-treatment... Previously, young breast cancer patients wer...ersity of Western Australia said, 'For women with ...
... cancer screening has proven helpful to abort almo...ever researchers opine that such //screening unnec...adiation. NHS offers regular screening tests ... women under the age of 50 as well, it would poten...
...y conducted by Minnesota students have revealed th...ng themselves daily are more prone to develop eati...ealthy crash diets. In spite of dieting, they end ...it, and use diet pills in order to lose weight. Pr...
Other Medicine News:Health News:Poly-pill – A Single Drug For Multiple Complaint 2Health News:Are You Health-Conscious or Tongue- Conscious? 2
... PSE Power Supply . The digital 200 V/2000 mA PSE... 10 mA increments. • It is possible to run up...t 55°C. Features: Direct reading of programme... time • Voltage, mA and timer adjustable duri...
PowerPac HV Power Supply
... PRODUCT SPECIFICATIONS Form: Granular, free-flowi...Gel Point (3%): less than or equal to 35C Reme...trength (3%): greater than or equal to 300 gm/... less than or equal to 0.10% DNase: Passes tes...
...ride (Cl) ≤ 500 mg/kg sulfate (SO 4 ) ≤... ≤ 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 m...04; 50 mg/kg Mg ≤ 50 mg/kg Mn ≤ 5 mg/k...04; 5 mg/kg Zn ≤ 5 mg/kg Special grade: for ...
Medicine Products: